April 20, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Use of molecular analysis […]
April 20, 2022
Emotional or sexual abuse in childhood may increase risk of multiple sclerosis (MS) in women, and risk may increase further with exposure to multiple kinds of […]
April 19, 2022
Can’t sleep? When slumber doesn’t come naturally, some are turning to melatonin, an over-the-counter sleep aid that often is mistaken for a supplement. This powerful hormone […]
April 19, 2022
A drug currently approved for tardive dyskinesia (TD) is also effective at treating Huntington’s disease (HD)–associated chorea, a movement disorder that affects most patients with HD, […]
April 18, 2022
CHARLESTON, W.Va. (AP) — West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. over the drugmaker’s […]
April 18, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways This study suggests and […]
April 15, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The results from this […]
April 13, 2022
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Novel reduced-dose intranasal oxytocin […]
April 12, 2022
Scientists believe they have developed a drug that neutralizes a neurotoxic chemical in the brain that triggers the degenerative process leading to Alzheimer’s disease (AD). The […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141
Next page